We do not accept responsibility for delays to packages, any additional charges relating to customs fees and duties
Remaining Challenges in ePA for GLP-1s While ePA greatly reduces friction, some challenges remain: Incomplete Payer Connectivity: Not every insurer will accept ePA for every drug/plan
The pattern is uncomfortable but clear: the single largest, best-powered Alzheimers trial of this class was negative, while the positive evidence is observational or confined to secondary endpoints in underpowered studies
*Contraindications weight loss injections include a personal or family history of medullary thyroid cancer, allergy to GLP-1 and weight loss injections, Type 1 Diabetes or history of Diabetic Ketoacidosis, personal or family history of Multiple Endocrine Neoplasia, personal history of Pancreatitis, renal impairment or kidney disease, gallbladder disease, or concurrent use of anti-diabetic medications or insulin